Japanese guidelines for the management of pemphigus

Masayuki Amagai, Akiko Tanikawa, Tomoko Shimizu, Takashi Hashimoto, Shigaku Ikeda, Michiko Kurosawa, Hironori Niizeki, Yumi Aoyama, Keiji Iwatsuki, Yasuo Kitajima

研究成果: Review article査読

60 被引用数 (Scopus)

抄録

The Committee for Guidelines for the Management of Pemphigus was organized as one element of the Japanese Dermatological Association (JDA) and the Ministry of Health, Labour, and Welfare (MHLW) Research Project on Measures for Research Committee for Intractable Skin Disease. Pemphigus has been defined as a group of intractable autoimmune blistering diseases caused by anti-desmoglein 1 and/or anti-desmoglein 3 IgG autoantibodies by the MHLW. The diagnosis of this condition and the criteria for assessing its severity are based on suggestions from the MHLW Research Group. The clinical practice guidelines presented here are those that are currently recommended in Japan. However, symptoms and complications can vary widely among individual pemphigus patients, so not all therapies will be required to be in complete agreement with these guidelines.

本文言語English
ページ(範囲)471-486
ページ数16
ジャーナルJournal of Dermatology
41
6
DOI
出版ステータスPublished - 2014 6月

ASJC Scopus subject areas

  • 皮膚病学

フィンガープリント

「Japanese guidelines for the management of pemphigus」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル